# RDN for CKD and Uncontrolled Hypertension Trial

Study · id `cardio:ct-nct07945795` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07945795](<https://clinicaltrials.gov/study/NCT07945795>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07945795

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 248 participants.

## Technical summary

Registry record NCT07945795. Randomized; single masking; primary purpose treatment. Start 2025-12-08 (actual); primary completion 2027-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 248 participants (planned count; ClinicalTrials.gov record NCT07945795, source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)
- Started: 2025-12-08 (actual) (ClinicalTrials.gov record NCT07945795, source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2027-10-31 (anticipated) (ClinicalTrials.gov record NCT07945795, source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)
- Completion: 2028-04-30 (anticipated) (ClinicalTrials.gov record NCT07945795, source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07945795, source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07945795-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: RDN for CKD and Uncontrolled Hypertension Trial
- Condition: Hypertension
- Condition: CKD - Chronic Kidney Disease
- Intervention (Device): Radiofrequency Renal Denervation System
- Intervention (Procedure): Parallel control
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

## Provenance

Content hash: 9c63202f2265b3425be5969476794c3d7a8e429bd3897319ea82ebec5c3acbb5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
